nodes	percent_of_prediction	percent_of_DWPC	metapath
Zonisamide—CA9—breast cancer	0.23	0.776	CbGaD
Zonisamide—AOX1—Raloxifene—breast cancer	0.101	0.375	CbGbCtD
Zonisamide—CYP3A4—breast cancer	0.0663	0.224	CbGaD
Zonisamide—AOX1—Methotrexate—breast cancer	0.0271	0.101	CbGbCtD
Zonisamide—CYP2C19—Lapatinib—breast cancer	0.0162	0.0603	CbGbCtD
Zonisamide—CYP3A4—Exemestane—breast cancer	0.0155	0.0577	CbGbCtD
Zonisamide—CYP3A4—Letrozole—breast cancer	0.0132	0.049	CbGbCtD
Zonisamide—CYP3A4—Anastrozole—breast cancer	0.0118	0.0437	CbGbCtD
Zonisamide—CYP3A4—Toremifene—breast cancer	0.0108	0.04	CbGbCtD
Zonisamide—CYP3A4—Fulvestrant—breast cancer	0.01	0.0372	CbGbCtD
Zonisamide—CYP3A4—Thiotepa—breast cancer	0.00892	0.0331	CbGbCtD
Zonisamide—CYP3A4—Ixabepilone—breast cancer	0.00816	0.0303	CbGbCtD
Zonisamide—CYP2C19—Tamoxifen—breast cancer	0.00813	0.0302	CbGbCtD
Zonisamide—CYP3A4—Lapatinib—breast cancer	0.00785	0.0292	CbGbCtD
Zonisamide—CYP3A4—Raloxifene—breast cancer	0.00595	0.0221	CbGbCtD
Zonisamide—CYP3A4—Vinorelbine—breast cancer	0.00436	0.0162	CbGbCtD
Zonisamide—CYP3A4—Tamoxifen—breast cancer	0.00393	0.0146	CbGbCtD
Zonisamide—CYP3A4—Mitoxantrone—breast cancer	0.00383	0.0142	CbGbCtD
Zonisamide—CYP3A4—Paclitaxel—breast cancer	0.00306	0.0114	CbGbCtD
Zonisamide—CYP3A4—Irinotecan—breast cancer	0.00302	0.0112	CbGbCtD
Zonisamide—CYP3A4—Vinblastine—breast cancer	0.00268	0.00997	CbGbCtD
Zonisamide—CYP3A4—Docetaxel—breast cancer	0.00221	0.00822	CbGbCtD
Zonisamide—SCN4B—nipple—breast cancer	0.00218	0.0276	CbGeAlD
Zonisamide—CA11—nipple—breast cancer	0.00188	0.0238	CbGeAlD
Zonisamide—CYP3A4—Doxorubicin—breast cancer	0.00165	0.00613	CbGbCtD
Zonisamide—CA8—endometrium—breast cancer	0.00158	0.02	CbGeAlD
Zonisamide—SCN1B—adipose tissue—breast cancer	0.00151	0.0192	CbGeAlD
Zonisamide—CA10—pituitary gland—breast cancer	0.00146	0.0184	CbGeAlD
Zonisamide—CA8—pituitary gland—breast cancer	0.00143	0.0181	CbGeAlD
Zonisamide—CA8—adipose tissue—breast cancer	0.00142	0.018	CbGeAlD
Zonisamide—SCN3B—pituitary gland—breast cancer	0.0014	0.0178	CbGeAlD
Zonisamide—SCN3B—adipose tissue—breast cancer	0.0014	0.0177	CbGeAlD
Zonisamide—SCN1B—female reproductive system—breast cancer	0.00139	0.0176	CbGeAlD
Zonisamide—SCN1B—adrenal gland—breast cancer	0.00136	0.0172	CbGeAlD
Zonisamide—CA10—female reproductive system—breast cancer	0.00133	0.0169	CbGeAlD
Zonisamide—CA8—adrenal gland—breast cancer	0.00128	0.0162	CbGeAlD
Zonisamide—SCN3B—adrenal gland—breast cancer	0.00125	0.0159	CbGeAlD
Zonisamide—CA13—adipose tissue—breast cancer	0.00122	0.0154	CbGeAlD
Zonisamide—SCN4B—pituitary gland—breast cancer	0.00119	0.0151	CbGeAlD
Zonisamide—SCN4B—adipose tissue—breast cancer	0.00119	0.015	CbGeAlD
Zonisamide—CA11—endometrium—breast cancer	0.00113	0.0144	CbGeAlD
Zonisamide—CA10—endocrine gland—breast cancer	0.00113	0.0143	CbGeAlD
Zonisamide—CA13—adrenal gland—breast cancer	0.00109	0.0138	CbGeAlD
Zonisamide—SCN4B—adrenal gland—breast cancer	0.00107	0.0135	CbGeAlD
Zonisamide—CA11—uterus—breast cancer	0.00105	0.0132	CbGeAlD
Zonisamide—CA11—pituitary gland—breast cancer	0.00103	0.013	CbGeAlD
Zonisamide—CA11—adipose tissue—breast cancer	0.00102	0.0129	CbGeAlD
Zonisamide—CA13—female gonad—breast cancer	0.00102	0.0129	CbGeAlD
Zonisamide—CA13—endocrine gland—breast cancer	0.000947	0.012	CbGeAlD
Zonisamide—CA5A—female reproductive system—breast cancer	0.00094	0.0119	CbGeAlD
Zonisamide—CA11—female reproductive system—breast cancer	0.00094	0.0119	CbGeAlD
Zonisamide—CA11—adrenal gland—breast cancer	0.000917	0.0116	CbGeAlD
Zonisamide—CA11—bone marrow—breast cancer	0.000887	0.0112	CbGeAlD
Zonisamide—CA5B—mammary gland—breast cancer	0.000881	0.0111	CbGeAlD
Zonisamide—CA11—female gonad—breast cancer	0.000855	0.0108	CbGeAlD
Zonisamide—SCN1B—lymph node—breast cancer	0.000814	0.0103	CbGeAlD
Zonisamide—CA5A—endocrine gland—breast cancer	0.000795	0.0101	CbGeAlD
Zonisamide—CA11—endocrine gland—breast cancer	0.000795	0.0101	CbGeAlD
Zonisamide—CA8—lymph node—breast cancer	0.000765	0.00969	CbGeAlD
Zonisamide—SCN3B—lymph node—breast cancer	0.000751	0.00951	CbGeAlD
Zonisamide—AOX1—nipple—breast cancer	0.000678	0.00858	CbGeAlD
Zonisamide—CA13—lymph node—breast cancer	0.000655	0.00829	CbGeAlD
Zonisamide—SCN4B—lymph node—breast cancer	0.000639	0.00809	CbGeAlD
Zonisamide—CA3—uterus—breast cancer	0.000638	0.00808	CbGeAlD
Zonisamide—CA3—pituitary gland—breast cancer	0.000627	0.00793	CbGeAlD
Zonisamide—CA3—adipose tissue—breast cancer	0.000624	0.0079	CbGeAlD
Zonisamide—CACNA1I—lymph node—breast cancer	0.000624	0.0079	CbGeAlD
Zonisamide—SCN9A—pituitary gland—breast cancer	0.000557	0.00706	CbGeAlD
Zonisamide—SCN9A—adipose tissue—breast cancer	0.000555	0.00703	CbGeAlD
Zonisamide—CA11—lymph node—breast cancer	0.00055	0.00696	CbGeAlD
Zonisamide—CA9—female reproductive system—breast cancer	0.000549	0.00695	CbGeAlD
Zonisamide—CA3—bone marrow—breast cancer	0.000542	0.00685	CbGeAlD
Zonisamide—CACNA1H—uterus—breast cancer	0.000532	0.00673	CbGeAlD
Zonisamide—CACNA1H—pituitary gland—breast cancer	0.000522	0.00661	CbGeAlD
Zonisamide—MAOB—nipple—breast cancer	0.000522	0.00661	CbGeAlD
Zonisamide—CA14—adrenal gland—breast cancer	0.000508	0.00643	CbGeAlD
Zonisamide—CA4—nipple—breast cancer	0.000503	0.00637	CbGeAlD
Zonisamide—SCN9A—adrenal gland—breast cancer	0.000498	0.0063	CbGeAlD
Zonisamide—SCN4A—pituitary gland—breast cancer	0.000497	0.0063	CbGeAlD
Zonisamide—SCN4A—adipose tissue—breast cancer	0.000495	0.00627	CbGeAlD
Zonisamide—CA3—endocrine gland—breast cancer	0.000485	0.00614	CbGeAlD
Zonisamide—CACNA1H—female reproductive system—breast cancer	0.000478	0.00605	CbGeAlD
Zonisamide—CACNA1H—adrenal gland—breast cancer	0.000467	0.00591	CbGeAlD
Zonisamide—CA9—endocrine gland—breast cancer	0.000465	0.00588	CbGeAlD
Zonisamide—MAOA—nipple—breast cancer	0.000445	0.00564	CbGeAlD
Zonisamide—SCN4A—adrenal gland—breast cancer	0.000444	0.00562	CbGeAlD
Zonisamide—SCN2A—pituitary gland—breast cancer	0.00044	0.00557	CbGeAlD
Zonisamide—CACNA1H—female gonad—breast cancer	0.000435	0.00551	CbGeAlD
Zonisamide—MAOB—embryo—breast cancer	0.000431	0.00545	CbGeAlD
Zonisamide—CA2—nipple—breast cancer	0.000417	0.00528	CbGeAlD
Zonisamide—AOX1—endometrium—breast cancer	0.000409	0.00518	CbGeAlD
Zonisamide—CA12—female reproductive system—breast cancer	0.000406	0.00514	CbGeAlD
Zonisamide—CACNA1H—endocrine gland—breast cancer	0.000405	0.00512	CbGeAlD
Zonisamide—CA5B—adipose tissue—breast cancer	0.000396	0.00502	CbGeAlD
Zonisamide—SCN3A—pituitary gland—breast cancer	0.000387	0.0049	CbGeAlD
Zonisamide—SCN3A—adipose tissue—breast cancer	0.000385	0.00488	CbGeAlD
Zonisamide—AOX1—uterus—breast cancer	0.000377	0.00477	CbGeAlD
Zonisamide—AOX1—pituitary gland—breast cancer	0.00037	0.00469	CbGeAlD
Zonisamide—AOX1—adipose tissue—breast cancer	0.000369	0.00467	CbGeAlD
Zonisamide—MAOA—embryo—breast cancer	0.000368	0.00465	CbGeAlD
Zonisamide—CA5B—female reproductive system—breast cancer	0.000364	0.00461	CbGeAlD
Zonisamide—CA5B—adrenal gland—breast cancer	0.000356	0.0045	CbGeAlD
Zonisamide—SCN3A—female reproductive system—breast cancer	0.000354	0.00448	CbGeAlD
Zonisamide—CA1—adipose tissue—breast cancer	0.00035	0.00443	CbGeAlD
Zonisamide—SCN3A—adrenal gland—breast cancer	0.000346	0.00437	CbGeAlD
Zonisamide—CA2—embryo—breast cancer	0.000344	0.00435	CbGeAlD
Zonisamide—CA12—endocrine gland—breast cancer	0.000344	0.00435	CbGeAlD
Zonisamide—SCN2A—endocrine gland—breast cancer	0.000341	0.00432	CbGeAlD
Zonisamide—AOX1—female reproductive system—breast cancer	0.000339	0.00429	CbGeAlD
Zonisamide—CA3—lymph node—breast cancer	0.000336	0.00425	CbGeAlD
Zonisamide—SCN3A—bone marrow—breast cancer	0.000334	0.00423	CbGeAlD
Zonisamide—AOX1—adrenal gland—breast cancer	0.000331	0.00419	CbGeAlD
Zonisamide—CA1—female reproductive system—breast cancer	0.000322	0.00407	CbGeAlD
Zonisamide—MAOB—endometrium—breast cancer	0.000315	0.00399	CbGeAlD
Zonisamide—AOX1—female gonad—breast cancer	0.000308	0.0039	CbGeAlD
Zonisamide—CA5B—endocrine gland—breast cancer	0.000308	0.0039	CbGeAlD
Zonisamide—CA1—bone marrow—breast cancer	0.000304	0.00385	CbGeAlD
Zonisamide—SCN9A—lymph node—breast cancer	0.000299	0.00378	CbGeAlD
Zonisamide—MAOB—uterus—breast cancer	0.00029	0.00368	CbGeAlD
Zonisamide—AOX1—endocrine gland—breast cancer	0.000287	0.00363	CbGeAlD
Zonisamide—MAOB—pituitary gland—breast cancer	0.000285	0.00361	CbGeAlD
Zonisamide—MAOB—adipose tissue—breast cancer	0.000284	0.0036	CbGeAlD
Zonisamide—CA2—epithelium—breast cancer	0.000281	0.00355	CbGeAlD
Zonisamide—CACNA1H—lymph node—breast cancer	0.00028	0.00354	CbGeAlD
Zonisamide—CA4—pituitary gland—breast cancer	0.000275	0.00348	CbGeAlD
Zonisamide—CA4—adipose tissue—breast cancer	0.000274	0.00346	CbGeAlD
Zonisamide—CA1—endocrine gland—breast cancer	0.000272	0.00345	CbGeAlD
Zonisamide—MAOA—endometrium—breast cancer	0.000269	0.0034	CbGeAlD
Zonisamide—CA2—skin of body—breast cancer	0.000267	0.00338	CbGeAlD
Zonisamide—MAOB—female reproductive system—breast cancer	0.000261	0.00331	CbGeAlD
Zonisamide—MAOB—adrenal gland—breast cancer	0.000255	0.00323	CbGeAlD
Zonisamide—CA4—female reproductive system—breast cancer	0.000252	0.00318	CbGeAlD
Zonisamide—MAOA—uterus—breast cancer	0.000248	0.00314	CbGeAlD
Zonisamide—CA4—adrenal gland—breast cancer	0.000245	0.00311	CbGeAlD
Zonisamide—MAOA—pituitary gland—breast cancer	0.000243	0.00308	CbGeAlD
Zonisamide—MAOA—adipose tissue—breast cancer	0.000242	0.00307	CbGeAlD
Zonisamide—MAOB—female gonad—breast cancer	0.000238	0.00301	CbGeAlD
Zonisamide—CA4—bone marrow—breast cancer	0.000237	0.00301	CbGeAlD
Zonisamide—CA4—female gonad—breast cancer	0.000229	0.0029	CbGeAlD
Zonisamide—CA2—pituitary gland—breast cancer	0.000228	0.00288	CbGeAlD
Zonisamide—CA2—adipose tissue—breast cancer	0.000227	0.00287	CbGeAlD
Zonisamide—MAOA—female reproductive system—breast cancer	0.000223	0.00282	CbGeAlD
Zonisamide—MAOB—endocrine gland—breast cancer	0.000221	0.0028	CbGeAlD
Zonisamide—MAOA—adrenal gland—breast cancer	0.000217	0.00275	CbGeAlD
Zonisamide—CA5B—lymph node—breast cancer	0.000213	0.0027	CbGeAlD
Zonisamide—CA4—endocrine gland—breast cancer	0.000213	0.00269	CbGeAlD
Zonisamide—CA2—female reproductive system—breast cancer	0.000209	0.00264	CbGeAlD
Zonisamide—SCN3A—lymph node—breast cancer	0.000207	0.00262	CbGeAlD
Zonisamide—CA2—adrenal gland—breast cancer	0.000204	0.00258	CbGeAlD
Zonisamide—MAOA—female gonad—breast cancer	0.000203	0.00257	CbGeAlD
Zonisamide—AOX1—lymph node—breast cancer	0.000198	0.00251	CbGeAlD
Zonisamide—CA2—bone marrow—breast cancer	0.000197	0.00249	CbGeAlD
Zonisamide—CYP2C19—endocrine gland—breast cancer	0.000193	0.00244	CbGeAlD
Zonisamide—CA2—female gonad—breast cancer	0.00019	0.0024	CbGeAlD
Zonisamide—MAOA—endocrine gland—breast cancer	0.000189	0.00239	CbGeAlD
Zonisamide—CA1—lymph node—breast cancer	0.000188	0.00238	CbGeAlD
Zonisamide—CA2—endocrine gland—breast cancer	0.000176	0.00223	CbGeAlD
Zonisamide—MAOB—lymph node—breast cancer	0.000153	0.00193	CbGeAlD
Zonisamide—CA4—lymph node—breast cancer	0.000147	0.00186	CbGeAlD
Zonisamide—CYP3A4—female reproductive system—breast cancer	0.000135	0.0017	CbGeAlD
Zonisamide—MAOA—lymph node—breast cancer	0.00013	0.00165	CbGeAlD
Zonisamide—CA2—lymph node—breast cancer	0.000122	0.00154	CbGeAlD
Zonisamide—CYP3A4—endocrine gland—breast cancer	0.000114	0.00144	CbGeAlD
Zonisamide—Dermatitis—Gemcitabine—breast cancer	3.14e-05	0.000156	CcSEcCtD
Zonisamide—Eye disorder—Epirubicin—breast cancer	3.13e-05	0.000156	CcSEcCtD
Zonisamide—Tinnitus—Epirubicin—breast cancer	3.13e-05	0.000156	CcSEcCtD
Zonisamide—Malnutrition—Methotrexate—breast cancer	3.12e-05	0.000155	CcSEcCtD
Zonisamide—Headache—Gemcitabine—breast cancer	3.12e-05	0.000155	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Capecitabine—breast cancer	3.12e-05	0.000155	CcSEcCtD
Zonisamide—Vomiting—Fluorouracil—breast cancer	3.11e-05	0.000155	CcSEcCtD
Zonisamide—Rhinitis—Doxorubicin—breast cancer	3.11e-05	0.000155	CcSEcCtD
Zonisamide—Dyspepsia—Docetaxel—breast cancer	3.11e-05	0.000155	CcSEcCtD
Zonisamide—Insomnia—Capecitabine—breast cancer	3.09e-05	0.000154	CcSEcCtD
Zonisamide—Rash—Fluorouracil—breast cancer	3.09e-05	0.000154	CcSEcCtD
Zonisamide—Dermatitis—Fluorouracil—breast cancer	3.08e-05	0.000154	CcSEcCtD
Zonisamide—Pharyngitis—Doxorubicin—breast cancer	3.08e-05	0.000153	CcSEcCtD
Zonisamide—Paraesthesia—Capecitabine—breast cancer	3.07e-05	0.000153	CcSEcCtD
Zonisamide—Decreased appetite—Docetaxel—breast cancer	3.07e-05	0.000153	CcSEcCtD
Zonisamide—Hypersensitivity—Paclitaxel—breast cancer	3.07e-05	0.000153	CcSEcCtD
Zonisamide—Headache—Fluorouracil—breast cancer	3.07e-05	0.000153	CcSEcCtD
Zonisamide—Urinary tract disorder—Doxorubicin—breast cancer	3.06e-05	0.000153	CcSEcCtD
Zonisamide—Oedema peripheral—Doxorubicin—breast cancer	3.06e-05	0.000152	CcSEcCtD
Zonisamide—Dysgeusia—Methotrexate—breast cancer	3.05e-05	0.000152	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Docetaxel—breast cancer	3.05e-05	0.000152	CcSEcCtD
Zonisamide—Connective tissue disorder—Doxorubicin—breast cancer	3.05e-05	0.000152	CcSEcCtD
Zonisamide—Dyspnoea—Capecitabine—breast cancer	3.05e-05	0.000152	CcSEcCtD
Zonisamide—Fatigue—Docetaxel—breast cancer	3.05e-05	0.000152	CcSEcCtD
Zonisamide—Urethral disorder—Doxorubicin—breast cancer	3.04e-05	0.000152	CcSEcCtD
Zonisamide—Nausea—Irinotecan—breast cancer	3.04e-05	0.000151	CcSEcCtD
Zonisamide—Nausea—Mitoxantrone—breast cancer	3.04e-05	0.000151	CcSEcCtD
Zonisamide—Immune system disorder—Epirubicin—breast cancer	3.03e-05	0.000151	CcSEcCtD
Zonisamide—Mediastinal disorder—Epirubicin—breast cancer	3.02e-05	0.000151	CcSEcCtD
Zonisamide—Constipation—Docetaxel—breast cancer	3.02e-05	0.000151	CcSEcCtD
Zonisamide—Dyspepsia—Capecitabine—breast cancer	3.01e-05	0.00015	CcSEcCtD
Zonisamide—Asthenia—Paclitaxel—breast cancer	2.99e-05	0.000149	CcSEcCtD
Zonisamide—Decreased appetite—Capecitabine—breast cancer	2.97e-05	0.000148	CcSEcCtD
Zonisamide—Alopecia—Epirubicin—breast cancer	2.96e-05	0.000148	CcSEcCtD
Zonisamide—Nausea—Gemcitabine—breast cancer	2.96e-05	0.000147	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Capecitabine—breast cancer	2.95e-05	0.000147	CcSEcCtD
Zonisamide—Fatigue—Capecitabine—breast cancer	2.95e-05	0.000147	CcSEcCtD
Zonisamide—Pruritus—Paclitaxel—breast cancer	2.95e-05	0.000147	CcSEcCtD
Zonisamide—Mental disorder—Epirubicin—breast cancer	2.94e-05	0.000146	CcSEcCtD
Zonisamide—Erythema multiforme—Doxorubicin—breast cancer	2.93e-05	0.000146	CcSEcCtD
Zonisamide—Constipation—Capecitabine—breast cancer	2.92e-05	0.000146	CcSEcCtD
Zonisamide—Malnutrition—Epirubicin—breast cancer	2.92e-05	0.000145	CcSEcCtD
Zonisamide—Feeling abnormal—Docetaxel—breast cancer	2.91e-05	0.000145	CcSEcCtD
Zonisamide—Nausea—Fluorouracil—breast cancer	2.91e-05	0.000145	CcSEcCtD
Zonisamide—Eye disorder—Doxorubicin—breast cancer	2.9e-05	0.000145	CcSEcCtD
Zonisamide—Ill-defined disorder—Methotrexate—breast cancer	2.89e-05	0.000144	CcSEcCtD
Zonisamide—Tinnitus—Doxorubicin—breast cancer	2.89e-05	0.000144	CcSEcCtD
Zonisamide—Gastrointestinal pain—Docetaxel—breast cancer	2.89e-05	0.000144	CcSEcCtD
Zonisamide—Anaemia—Methotrexate—breast cancer	2.88e-05	0.000144	CcSEcCtD
Zonisamide—Flatulence—Epirubicin—breast cancer	2.88e-05	0.000143	CcSEcCtD
Zonisamide—Tension—Epirubicin—breast cancer	2.86e-05	0.000143	CcSEcCtD
Zonisamide—Dysgeusia—Epirubicin—breast cancer	2.86e-05	0.000142	CcSEcCtD
Zonisamide—Diarrhoea—Paclitaxel—breast cancer	2.85e-05	0.000142	CcSEcCtD
Zonisamide—Nervousness—Epirubicin—breast cancer	2.84e-05	0.000141	CcSEcCtD
Zonisamide—Feeling abnormal—Capecitabine—breast cancer	2.82e-05	0.00014	CcSEcCtD
Zonisamide—Malaise—Methotrexate—breast cancer	2.81e-05	0.00014	CcSEcCtD
Zonisamide—Muscle spasms—Epirubicin—breast cancer	2.81e-05	0.00014	CcSEcCtD
Zonisamide—Immune system disorder—Doxorubicin—breast cancer	2.8e-05	0.00014	CcSEcCtD
Zonisamide—Vertigo—Methotrexate—breast cancer	2.8e-05	0.00014	CcSEcCtD
Zonisamide—Gastrointestinal pain—Capecitabine—breast cancer	2.8e-05	0.000139	CcSEcCtD
Zonisamide—Mediastinal disorder—Doxorubicin—breast cancer	2.8e-05	0.000139	CcSEcCtD
Zonisamide—Abdominal pain—Docetaxel—breast cancer	2.79e-05	0.000139	CcSEcCtD
Zonisamide—Body temperature increased—Docetaxel—breast cancer	2.79e-05	0.000139	CcSEcCtD
Zonisamide—Leukopenia—Methotrexate—breast cancer	2.79e-05	0.000139	CcSEcCtD
Zonisamide—Dizziness—Paclitaxel—breast cancer	2.76e-05	0.000137	CcSEcCtD
Zonisamide—Alopecia—Doxorubicin—breast cancer	2.74e-05	0.000137	CcSEcCtD
Zonisamide—Cough—Methotrexate—breast cancer	2.72e-05	0.000136	CcSEcCtD
Zonisamide—Mental disorder—Doxorubicin—breast cancer	2.72e-05	0.000135	CcSEcCtD
Zonisamide—Urticaria—Capecitabine—breast cancer	2.72e-05	0.000135	CcSEcCtD
Zonisamide—Ill-defined disorder—Epirubicin—breast cancer	2.71e-05	0.000135	CcSEcCtD
Zonisamide—Body temperature increased—Capecitabine—breast cancer	2.7e-05	0.000135	CcSEcCtD
Zonisamide—Abdominal pain—Capecitabine—breast cancer	2.7e-05	0.000135	CcSEcCtD
Zonisamide—Convulsion—Methotrexate—breast cancer	2.7e-05	0.000135	CcSEcCtD
Zonisamide—Malnutrition—Doxorubicin—breast cancer	2.7e-05	0.000135	CcSEcCtD
Zonisamide—Anaemia—Epirubicin—breast cancer	2.7e-05	0.000134	CcSEcCtD
Zonisamide—Agitation—Epirubicin—breast cancer	2.68e-05	0.000134	CcSEcCtD
Zonisamide—Flatulence—Doxorubicin—breast cancer	2.66e-05	0.000133	CcSEcCtD
Zonisamide—Arthralgia—Methotrexate—breast cancer	2.66e-05	0.000132	CcSEcCtD
Zonisamide—Myalgia—Methotrexate—breast cancer	2.66e-05	0.000132	CcSEcCtD
Zonisamide—Chest pain—Methotrexate—breast cancer	2.66e-05	0.000132	CcSEcCtD
Zonisamide—Tension—Doxorubicin—breast cancer	2.65e-05	0.000132	CcSEcCtD
Zonisamide—Vomiting—Paclitaxel—breast cancer	2.65e-05	0.000132	CcSEcCtD
Zonisamide—Dysgeusia—Doxorubicin—breast cancer	2.65e-05	0.000132	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	2.64e-05	0.000131	CcSEcCtD
Zonisamide—Malaise—Epirubicin—breast cancer	2.63e-05	0.000131	CcSEcCtD
Zonisamide—Rash—Paclitaxel—breast cancer	2.63e-05	0.000131	CcSEcCtD
Zonisamide—Dermatitis—Paclitaxel—breast cancer	2.63e-05	0.000131	CcSEcCtD
Zonisamide—Discomfort—Methotrexate—breast cancer	2.62e-05	0.000131	CcSEcCtD
Zonisamide—Nervousness—Doxorubicin—breast cancer	2.62e-05	0.000131	CcSEcCtD
Zonisamide—Vertigo—Epirubicin—breast cancer	2.62e-05	0.000131	CcSEcCtD
Zonisamide—Syncope—Epirubicin—breast cancer	2.62e-05	0.00013	CcSEcCtD
Zonisamide—Leukopenia—Epirubicin—breast cancer	2.61e-05	0.00013	CcSEcCtD
Zonisamide—Headache—Paclitaxel—breast cancer	2.61e-05	0.00013	CcSEcCtD
Zonisamide—Hypersensitivity—Docetaxel—breast cancer	2.6e-05	0.00013	CcSEcCtD
Zonisamide—Muscle spasms—Doxorubicin—breast cancer	2.6e-05	0.000129	CcSEcCtD
Zonisamide—Palpitations—Epirubicin—breast cancer	2.58e-05	0.000129	CcSEcCtD
Zonisamide—Confusional state—Methotrexate—breast cancer	2.57e-05	0.000128	CcSEcCtD
Zonisamide—Loss of consciousness—Epirubicin—breast cancer	2.57e-05	0.000128	CcSEcCtD
Zonisamide—Cough—Epirubicin—breast cancer	2.55e-05	0.000127	CcSEcCtD
Zonisamide—Asthenia—Docetaxel—breast cancer	2.53e-05	0.000126	CcSEcCtD
Zonisamide—Convulsion—Epirubicin—breast cancer	2.53e-05	0.000126	CcSEcCtD
Zonisamide—Infection—Methotrexate—breast cancer	2.53e-05	0.000126	CcSEcCtD
Zonisamide—Hypertension—Epirubicin—breast cancer	2.52e-05	0.000126	CcSEcCtD
Zonisamide—Hypersensitivity—Capecitabine—breast cancer	2.52e-05	0.000126	CcSEcCtD
Zonisamide—Ill-defined disorder—Doxorubicin—breast cancer	2.51e-05	0.000125	CcSEcCtD
Zonisamide—Pruritus—Docetaxel—breast cancer	2.5e-05	0.000125	CcSEcCtD
Zonisamide—Nervous system disorder—Methotrexate—breast cancer	2.5e-05	0.000124	CcSEcCtD
Zonisamide—Anaemia—Doxorubicin—breast cancer	2.5e-05	0.000124	CcSEcCtD
Zonisamide—Thrombocytopenia—Methotrexate—breast cancer	2.49e-05	0.000124	CcSEcCtD
Zonisamide—Myalgia—Epirubicin—breast cancer	2.49e-05	0.000124	CcSEcCtD
Zonisamide—Chest pain—Epirubicin—breast cancer	2.49e-05	0.000124	CcSEcCtD
Zonisamide—Arthralgia—Epirubicin—breast cancer	2.49e-05	0.000124	CcSEcCtD
Zonisamide—Agitation—Doxorubicin—breast cancer	2.48e-05	0.000124	CcSEcCtD
Zonisamide—Anxiety—Epirubicin—breast cancer	2.48e-05	0.000123	CcSEcCtD
Zonisamide—Nausea—Paclitaxel—breast cancer	2.48e-05	0.000123	CcSEcCtD
Zonisamide—Skin disorder—Methotrexate—breast cancer	2.47e-05	0.000123	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.47e-05	0.000123	CcSEcCtD
Zonisamide—Hyperhidrosis—Methotrexate—breast cancer	2.46e-05	0.000123	CcSEcCtD
Zonisamide—Discomfort—Epirubicin—breast cancer	2.46e-05	0.000122	CcSEcCtD
Zonisamide—Asthenia—Capecitabine—breast cancer	2.45e-05	0.000122	CcSEcCtD
Zonisamide—Malaise—Doxorubicin—breast cancer	2.44e-05	0.000121	CcSEcCtD
Zonisamide—Dry mouth—Epirubicin—breast cancer	2.43e-05	0.000121	CcSEcCtD
Zonisamide—Vertigo—Doxorubicin—breast cancer	2.43e-05	0.000121	CcSEcCtD
Zonisamide—Anorexia—Methotrexate—breast cancer	2.43e-05	0.000121	CcSEcCtD
Zonisamide—Syncope—Doxorubicin—breast cancer	2.42e-05	0.000121	CcSEcCtD
Zonisamide—Pruritus—Capecitabine—breast cancer	2.42e-05	0.000121	CcSEcCtD
Zonisamide—Leukopenia—Doxorubicin—breast cancer	2.42e-05	0.00012	CcSEcCtD
Zonisamide—Diarrhoea—Docetaxel—breast cancer	2.42e-05	0.00012	CcSEcCtD
Zonisamide—Confusional state—Epirubicin—breast cancer	2.4e-05	0.00012	CcSEcCtD
Zonisamide—Palpitations—Doxorubicin—breast cancer	2.39e-05	0.000119	CcSEcCtD
Zonisamide—Oedema—Epirubicin—breast cancer	2.38e-05	0.000119	CcSEcCtD
Zonisamide—Hypotension—Methotrexate—breast cancer	2.38e-05	0.000119	CcSEcCtD
Zonisamide—Loss of consciousness—Doxorubicin—breast cancer	2.37e-05	0.000118	CcSEcCtD
Zonisamide—Infection—Epirubicin—breast cancer	2.37e-05	0.000118	CcSEcCtD
Zonisamide—Cough—Doxorubicin—breast cancer	2.36e-05	0.000117	CcSEcCtD
Zonisamide—Shock—Epirubicin—breast cancer	2.34e-05	0.000117	CcSEcCtD
Zonisamide—Convulsion—Doxorubicin—breast cancer	2.34e-05	0.000117	CcSEcCtD
Zonisamide—Diarrhoea—Capecitabine—breast cancer	2.34e-05	0.000117	CcSEcCtD
Zonisamide—Nervous system disorder—Epirubicin—breast cancer	2.34e-05	0.000116	CcSEcCtD
Zonisamide—Dizziness—Docetaxel—breast cancer	2.34e-05	0.000116	CcSEcCtD
Zonisamide—Thrombocytopenia—Epirubicin—breast cancer	2.33e-05	0.000116	CcSEcCtD
Zonisamide—Hypertension—Doxorubicin—breast cancer	2.33e-05	0.000116	CcSEcCtD
Zonisamide—Tachycardia—Epirubicin—breast cancer	2.33e-05	0.000116	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Methotrexate—breast cancer	2.32e-05	0.000116	CcSEcCtD
Zonisamide—Skin disorder—Epirubicin—breast cancer	2.31e-05	0.000115	CcSEcCtD
Zonisamide—Hyperhidrosis—Epirubicin—breast cancer	2.3e-05	0.000115	CcSEcCtD
Zonisamide—Insomnia—Methotrexate—breast cancer	2.3e-05	0.000115	CcSEcCtD
Zonisamide—Chest pain—Doxorubicin—breast cancer	2.3e-05	0.000115	CcSEcCtD
Zonisamide—Myalgia—Doxorubicin—breast cancer	2.3e-05	0.000115	CcSEcCtD
Zonisamide—Arthralgia—Doxorubicin—breast cancer	2.3e-05	0.000115	CcSEcCtD
Zonisamide—Anxiety—Doxorubicin—breast cancer	2.29e-05	0.000114	CcSEcCtD
Zonisamide—Paraesthesia—Methotrexate—breast cancer	2.29e-05	0.000114	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.28e-05	0.000114	CcSEcCtD
Zonisamide—Discomfort—Doxorubicin—breast cancer	2.27e-05	0.000113	CcSEcCtD
Zonisamide—Anorexia—Epirubicin—breast cancer	2.27e-05	0.000113	CcSEcCtD
Zonisamide—Dyspnoea—Methotrexate—breast cancer	2.27e-05	0.000113	CcSEcCtD
Zonisamide—Somnolence—Methotrexate—breast cancer	2.26e-05	0.000113	CcSEcCtD
Zonisamide—Dizziness—Capecitabine—breast cancer	2.26e-05	0.000113	CcSEcCtD
Zonisamide—Dry mouth—Doxorubicin—breast cancer	2.25e-05	0.000112	CcSEcCtD
Zonisamide—Vomiting—Docetaxel—breast cancer	2.25e-05	0.000112	CcSEcCtD
Zonisamide—Dyspepsia—Methotrexate—breast cancer	2.24e-05	0.000112	CcSEcCtD
Zonisamide—Rash—Docetaxel—breast cancer	2.23e-05	0.000111	CcSEcCtD
Zonisamide—Hypotension—Epirubicin—breast cancer	2.23e-05	0.000111	CcSEcCtD
Zonisamide—Dermatitis—Docetaxel—breast cancer	2.23e-05	0.000111	CcSEcCtD
Zonisamide—Confusional state—Doxorubicin—breast cancer	2.22e-05	0.000111	CcSEcCtD
Zonisamide—Decreased appetite—Methotrexate—breast cancer	2.21e-05	0.00011	CcSEcCtD
Zonisamide—Headache—Docetaxel—breast cancer	2.21e-05	0.00011	CcSEcCtD
Zonisamide—Oedema—Doxorubicin—breast cancer	2.2e-05	0.00011	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Methotrexate—breast cancer	2.2e-05	0.00011	CcSEcCtD
Zonisamide—Fatigue—Methotrexate—breast cancer	2.2e-05	0.000109	CcSEcCtD
Zonisamide—Infection—Doxorubicin—breast cancer	2.19e-05	0.000109	CcSEcCtD
Zonisamide—Vomiting—Capecitabine—breast cancer	2.17e-05	0.000108	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Epirubicin—breast cancer	2.17e-05	0.000108	CcSEcCtD
Zonisamide—Shock—Doxorubicin—breast cancer	2.17e-05	0.000108	CcSEcCtD
Zonisamide—Nervous system disorder—Doxorubicin—breast cancer	2.16e-05	0.000108	CcSEcCtD
Zonisamide—Thrombocytopenia—Doxorubicin—breast cancer	2.16e-05	0.000108	CcSEcCtD
Zonisamide—Rash—Capecitabine—breast cancer	2.16e-05	0.000107	CcSEcCtD
Zonisamide—Insomnia—Epirubicin—breast cancer	2.16e-05	0.000107	CcSEcCtD
Zonisamide—Dermatitis—Capecitabine—breast cancer	2.15e-05	0.000107	CcSEcCtD
Zonisamide—Tachycardia—Doxorubicin—breast cancer	2.15e-05	0.000107	CcSEcCtD
Zonisamide—Headache—Capecitabine—breast cancer	2.14e-05	0.000107	CcSEcCtD
Zonisamide—Skin disorder—Doxorubicin—breast cancer	2.14e-05	0.000107	CcSEcCtD
Zonisamide—Paraesthesia—Epirubicin—breast cancer	2.14e-05	0.000107	CcSEcCtD
Zonisamide—Hyperhidrosis—Doxorubicin—breast cancer	2.13e-05	0.000106	CcSEcCtD
Zonisamide—Dyspnoea—Epirubicin—breast cancer	2.12e-05	0.000106	CcSEcCtD
Zonisamide—Somnolence—Epirubicin—breast cancer	2.12e-05	0.000106	CcSEcCtD
Zonisamide—Anorexia—Doxorubicin—breast cancer	2.1e-05	0.000105	CcSEcCtD
Zonisamide—Nausea—Docetaxel—breast cancer	2.1e-05	0.000105	CcSEcCtD
Zonisamide—Feeling abnormal—Methotrexate—breast cancer	2.1e-05	0.000105	CcSEcCtD
Zonisamide—Dyspepsia—Epirubicin—breast cancer	2.1e-05	0.000105	CcSEcCtD
Zonisamide—Gastrointestinal pain—Methotrexate—breast cancer	2.08e-05	0.000104	CcSEcCtD
Zonisamide—Decreased appetite—Epirubicin—breast cancer	2.07e-05	0.000103	CcSEcCtD
Zonisamide—Hypotension—Doxorubicin—breast cancer	2.06e-05	0.000103	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Epirubicin—breast cancer	2.06e-05	0.000103	CcSEcCtD
Zonisamide—Fatigue—Epirubicin—breast cancer	2.05e-05	0.000102	CcSEcCtD
Zonisamide—Constipation—Epirubicin—breast cancer	2.04e-05	0.000102	CcSEcCtD
Zonisamide—Nausea—Capecitabine—breast cancer	2.03e-05	0.000101	CcSEcCtD
Zonisamide—Urticaria—Methotrexate—breast cancer	2.02e-05	0.000101	CcSEcCtD
Zonisamide—Body temperature increased—Methotrexate—breast cancer	2.01e-05	0.0001	CcSEcCtD
Zonisamide—Abdominal pain—Methotrexate—breast cancer	2.01e-05	0.0001	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.01e-05	0.0001	CcSEcCtD
Zonisamide—Insomnia—Doxorubicin—breast cancer	1.99e-05	9.94e-05	CcSEcCtD
Zonisamide—Paraesthesia—Doxorubicin—breast cancer	1.98e-05	9.87e-05	CcSEcCtD
Zonisamide—Dyspnoea—Doxorubicin—breast cancer	1.97e-05	9.79e-05	CcSEcCtD
Zonisamide—Feeling abnormal—Epirubicin—breast cancer	1.96e-05	9.78e-05	CcSEcCtD
Zonisamide—Somnolence—Doxorubicin—breast cancer	1.96e-05	9.77e-05	CcSEcCtD
Zonisamide—Gastrointestinal pain—Epirubicin—breast cancer	1.95e-05	9.71e-05	CcSEcCtD
Zonisamide—Dyspepsia—Doxorubicin—breast cancer	1.94e-05	9.67e-05	CcSEcCtD
Zonisamide—Decreased appetite—Doxorubicin—breast cancer	1.92e-05	9.55e-05	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Doxorubicin—breast cancer	1.9e-05	9.48e-05	CcSEcCtD
Zonisamide—Fatigue—Doxorubicin—breast cancer	1.9e-05	9.47e-05	CcSEcCtD
Zonisamide—Urticaria—Epirubicin—breast cancer	1.89e-05	9.43e-05	CcSEcCtD
Zonisamide—Constipation—Doxorubicin—breast cancer	1.89e-05	9.4e-05	CcSEcCtD
Zonisamide—Abdominal pain—Epirubicin—breast cancer	1.88e-05	9.39e-05	CcSEcCtD
Zonisamide—Body temperature increased—Epirubicin—breast cancer	1.88e-05	9.39e-05	CcSEcCtD
Zonisamide—Hypersensitivity—Methotrexate—breast cancer	1.88e-05	9.35e-05	CcSEcCtD
Zonisamide—Asthenia—Methotrexate—breast cancer	1.83e-05	9.1e-05	CcSEcCtD
Zonisamide—Feeling abnormal—Doxorubicin—breast cancer	1.82e-05	9.05e-05	CcSEcCtD
Zonisamide—Gastrointestinal pain—Doxorubicin—breast cancer	1.8e-05	8.98e-05	CcSEcCtD
Zonisamide—Pruritus—Methotrexate—breast cancer	1.8e-05	8.98e-05	CcSEcCtD
Zonisamide—Hypersensitivity—Epirubicin—breast cancer	1.76e-05	8.75e-05	CcSEcCtD
Zonisamide—Urticaria—Doxorubicin—breast cancer	1.75e-05	8.73e-05	CcSEcCtD
Zonisamide—Abdominal pain—Doxorubicin—breast cancer	1.74e-05	8.68e-05	CcSEcCtD
Zonisamide—Body temperature increased—Doxorubicin—breast cancer	1.74e-05	8.68e-05	CcSEcCtD
Zonisamide—Diarrhoea—Methotrexate—breast cancer	1.74e-05	8.68e-05	CcSEcCtD
Zonisamide—Asthenia—Epirubicin—breast cancer	1.71e-05	8.52e-05	CcSEcCtD
Zonisamide—Pruritus—Epirubicin—breast cancer	1.69e-05	8.4e-05	CcSEcCtD
Zonisamide—Dizziness—Methotrexate—breast cancer	1.68e-05	8.39e-05	CcSEcCtD
Zonisamide—Diarrhoea—Epirubicin—breast cancer	1.63e-05	8.12e-05	CcSEcCtD
Zonisamide—Hypersensitivity—Doxorubicin—breast cancer	1.62e-05	8.09e-05	CcSEcCtD
Zonisamide—Vomiting—Methotrexate—breast cancer	1.62e-05	8.07e-05	CcSEcCtD
Zonisamide—Rash—Methotrexate—breast cancer	1.61e-05	8e-05	CcSEcCtD
Zonisamide—Dermatitis—Methotrexate—breast cancer	1.6e-05	7.99e-05	CcSEcCtD
Zonisamide—Headache—Methotrexate—breast cancer	1.59e-05	7.95e-05	CcSEcCtD
Zonisamide—Asthenia—Doxorubicin—breast cancer	1.58e-05	7.88e-05	CcSEcCtD
Zonisamide—Dizziness—Epirubicin—breast cancer	1.58e-05	7.85e-05	CcSEcCtD
Zonisamide—Pruritus—Doxorubicin—breast cancer	1.56e-05	7.77e-05	CcSEcCtD
Zonisamide—Vomiting—Epirubicin—breast cancer	1.51e-05	7.55e-05	CcSEcCtD
Zonisamide—Nausea—Methotrexate—breast cancer	1.51e-05	7.54e-05	CcSEcCtD
Zonisamide—Diarrhoea—Doxorubicin—breast cancer	1.51e-05	7.52e-05	CcSEcCtD
Zonisamide—Rash—Epirubicin—breast cancer	1.5e-05	7.49e-05	CcSEcCtD
Zonisamide—Dermatitis—Epirubicin—breast cancer	1.5e-05	7.48e-05	CcSEcCtD
Zonisamide—Headache—Epirubicin—breast cancer	1.49e-05	7.44e-05	CcSEcCtD
Zonisamide—Dizziness—Doxorubicin—breast cancer	1.46e-05	7.27e-05	CcSEcCtD
Zonisamide—Nausea—Epirubicin—breast cancer	1.42e-05	7.05e-05	CcSEcCtD
Zonisamide—Vomiting—Doxorubicin—breast cancer	1.4e-05	6.99e-05	CcSEcCtD
Zonisamide—Rash—Doxorubicin—breast cancer	1.39e-05	6.93e-05	CcSEcCtD
Zonisamide—Dermatitis—Doxorubicin—breast cancer	1.39e-05	6.92e-05	CcSEcCtD
Zonisamide—Headache—Doxorubicin—breast cancer	1.38e-05	6.88e-05	CcSEcCtD
Zonisamide—Nausea—Doxorubicin—breast cancer	1.31e-05	6.53e-05	CcSEcCtD
Zonisamide—CA4—Metabolism—PTGS2—breast cancer	3.3e-06	2.13e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—STK11—breast cancer	3.29e-06	2.13e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CYP19A1—breast cancer	3.29e-06	2.13e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—NOS3—breast cancer	3.26e-06	2.1e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PIK3CB—breast cancer	3.2e-06	2.06e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—CTNNB1—breast cancer	3.18e-06	2.05e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PTGS2—breast cancer	3.17e-06	2.05e-05	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—HRAS—breast cancer	3.16e-06	2.04e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ABCC1—breast cancer	3.16e-06	2.04e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—HMMR—breast cancer	3.16e-06	2.04e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTA3—breast cancer	3.16e-06	2.04e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—CDKN1A—breast cancer	3.11e-06	2.01e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CHST9—breast cancer	3.11e-06	2.01e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—PTEN—breast cancer	3.1e-06	2e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PIK3CD—breast cancer	3.09e-06	2e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PIK3CB—breast cancer	3.07e-06	1.98e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—COMT—breast cancer	3.06e-06	1.98e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PPARGC1B—breast cancer	3.06e-06	1.97e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—ALB—breast cancer	3.05e-06	1.97e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GSTP1—breast cancer	3.05e-06	1.97e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PTGS2—breast cancer	3.04e-06	1.96e-05	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PIK3CA—breast cancer	3.02e-06	1.95e-05	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—IL6—breast cancer	3.02e-06	1.95e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—HMOX1—breast cancer	3.01e-06	1.94e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PIK3CB—breast cancer	3.01e-06	1.94e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—ITPR1—breast cancer	3e-06	1.94e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PTGS2—breast cancer	2.98e-06	1.92e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	2.98e-06	1.92e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	2.98e-06	1.92e-05	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PIK3CA—breast cancer	2.95e-06	1.9e-05	CbGpPWpGaD
Zonisamide—CA6—Metabolism—PIK3CA—breast cancer	2.95e-06	1.9e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—COX11—breast cancer	2.95e-06	1.9e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—NOS3—breast cancer	2.92e-06	1.88e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PIK3CD—breast cancer	2.91e-06	1.88e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CA9—breast cancer	2.89e-06	1.86e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTA4—breast cancer	2.89e-06	1.86e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—ABCB1—breast cancer	2.89e-06	1.86e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PTEN—breast cancer	2.88e-06	1.86e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—ALB—breast cancer	2.88e-06	1.86e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—SRC—breast cancer	2.88e-06	1.86e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—breast cancer	2.85e-06	1.84e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—TYMS—breast cancer	2.83e-06	1.83e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	2.82e-06	1.82e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTA2—breast cancer	2.81e-06	1.82e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GPX2—breast cancer	2.81e-06	1.82e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GSTM1—breast cancer	2.8e-06	1.81e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—NCOR1—breast cancer	2.8e-06	1.81e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PLA2G4A—breast cancer	2.8e-06	1.81e-05	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—AKT1—breast cancer	2.79e-06	1.8e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SULT1A1—breast cancer	2.78e-06	1.79e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GPX4—breast cancer	2.78e-06	1.79e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—STAT3—breast cancer	2.77e-06	1.79e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PTEN—breast cancer	2.76e-06	1.78e-05	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PIK3CA—breast cancer	2.75e-06	1.78e-05	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PIK3CA—breast cancer	2.75e-06	1.78e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—NOS3—breast cancer	2.75e-06	1.78e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTA1—breast cancer	2.72e-06	1.75e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—IDH1—breast cancer	2.72e-06	1.75e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SHMT1—breast cancer	2.7e-06	1.74e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CDA—breast cancer	2.7e-06	1.74e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PIK3CB—breast cancer	2.7e-06	1.74e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NAT2—breast cancer	2.68e-06	1.73e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GPX1—breast cancer	2.68e-06	1.73e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PTGS2—breast cancer	2.67e-06	1.72e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CYP1A1—breast cancer	2.66e-06	1.71e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—MAPK3—breast cancer	2.65e-06	1.71e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PTEN—breast cancer	2.65e-06	1.71e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—ERCC2—breast cancer	2.63e-06	1.7e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PTEN—breast cancer	2.6e-06	1.68e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SLC2A5—breast cancer	2.59e-06	1.67e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SLCO1B1—breast cancer	2.59e-06	1.67e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—MYC—breast cancer	2.58e-06	1.66e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—TGFB1—breast cancer	2.57e-06	1.66e-05	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PIK3CA—breast cancer	2.55e-06	1.65e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PIK3CB—breast cancer	2.54e-06	1.64e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—EGFR—breast cancer	2.52e-06	1.63e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PTGS2—breast cancer	2.52e-06	1.62e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—APRT—breast cancer	2.51e-06	1.62e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—MTHFR—breast cancer	2.48e-06	1.6e-05	CbGpPWpGaD
Zonisamide—CA14—Metabolism—AKT1—breast cancer	2.47e-06	1.6e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—breast cancer	2.43e-06	1.57e-05	CbGpPWpGaD
Zonisamide—CA6—Metabolism—AKT1—breast cancer	2.41e-06	1.55e-05	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—AKT1—breast cancer	2.41e-06	1.55e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—KRAS—breast cancer	2.38e-06	1.54e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ESRRA—breast cancer	2.36e-06	1.52e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ANGPTL4—breast cancer	2.36e-06	1.52e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—DPYD—breast cancer	2.35e-06	1.52e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—MED12—breast cancer	2.35e-06	1.52e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PTEN—breast cancer	2.33e-06	1.5e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ALDOA—breast cancer	2.32e-06	1.5e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CAV1—breast cancer	2.28e-06	1.47e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NCOA3—breast cancer	2.25e-06	1.45e-05	CbGpPWpGaD
Zonisamide—CA7—Metabolism—AKT1—breast cancer	2.25e-06	1.45e-05	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—AKT1—breast cancer	2.25e-06	1.45e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SLC2A2—breast cancer	2.23e-06	1.44e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—HADHB—breast cancer	2.23e-06	1.44e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GPI—breast cancer	2.23e-06	1.44e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	2.21e-06	1.43e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PTEN—breast cancer	2.2e-06	1.42e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ABCG2—breast cancer	2.19e-06	1.41e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CPT1A—breast cancer	2.19e-06	1.41e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—MTR—breast cancer	2.19e-06	1.41e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—PIK3CA—breast cancer	2.19e-06	1.41e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—HPGDS—breast cancer	2.15e-06	1.39e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—HBA1—breast cancer	2.13e-06	1.38e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ALDH1A1—breast cancer	2.13e-06	1.38e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ALDH7A1—breast cancer	2.13e-06	1.38e-05	CbGpPWpGaD
Zonisamide—CA12—Metabolism—AKT1—breast cancer	2.08e-06	1.34e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTT1—breast cancer	2.08e-06	1.34e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ACHE—breast cancer	2.08e-06	1.34e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PIK3CG—breast cancer	2.08e-06	1.34e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—UMPS—breast cancer	2.04e-06	1.32e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NME1—breast cancer	2.04e-06	1.32e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—FHL2—breast cancer	2.04e-06	1.32e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PHGDH—breast cancer	2.04e-06	1.32e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ADSL—breast cancer	2.04e-06	1.32e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PIK3CA—breast cancer	2.03e-06	1.31e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—HRAS—breast cancer	2.02e-06	1.31e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—LDHB—breast cancer	2e-06	1.29e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—HPSE—breast cancer	2e-06	1.29e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—BRIP1—breast cancer	2e-06	1.29e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP17A1—breast cancer	1.97e-06	1.27e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ENO1—breast cancer	1.95e-06	1.26e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PTGS1—breast cancer	1.95e-06	1.26e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PIK3CA—breast cancer	1.95e-06	1.26e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.94e-06	1.25e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—IL6—breast cancer	1.94e-06	1.25e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.92e-06	1.24e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP2D6—breast cancer	1.91e-06	1.24e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTA3—breast cancer	1.9e-06	1.23e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ABCC1—breast cancer	1.9e-06	1.23e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—HMMR—breast cancer	1.9e-06	1.23e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NCOA2—breast cancer	1.88e-06	1.21e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PIK3CA—breast cancer	1.87e-06	1.21e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PPARGC1B—breast cancer	1.84e-06	1.19e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PIK3CA—breast cancer	1.83e-06	1.18e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PIK3CD—breast cancer	1.83e-06	1.18e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—FASN—breast cancer	1.82e-06	1.18e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—BCHE—breast cancer	1.81e-06	1.17e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—ALB—breast cancer	1.81e-06	1.17e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SLC5A5—breast cancer	1.79e-06	1.16e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—AKT1—breast cancer	1.79e-06	1.15e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTA4—breast cancer	1.74e-06	1.12e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CA9—breast cancer	1.74e-06	1.12e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NQO1—breast cancer	1.73e-06	1.12e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SLC2A1—breast cancer	1.73e-06	1.12e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—NOS3—breast cancer	1.73e-06	1.11e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.69e-06	1.09e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTA2—breast cancer	1.69e-06	1.09e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GPX2—breast cancer	1.69e-06	1.09e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP3A4—breast cancer	1.69e-06	1.09e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.68e-06	1.08e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SULT1A1—breast cancer	1.67e-06	1.08e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GPX4—breast cancer	1.67e-06	1.08e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—AKT1—breast cancer	1.66e-06	1.07e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP1B1—breast cancer	1.66e-06	1.07e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PIK3CA—breast cancer	1.64e-06	1.06e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—IDH1—breast cancer	1.63e-06	1.05e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTA1—breast cancer	1.63e-06	1.05e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—HSP90AA1—breast cancer	1.63e-06	1.05e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NAT2—breast cancer	1.61e-06	1.04e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PIK3CB—breast cancer	1.59e-06	1.03e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—AKT1—breast cancer	1.59e-06	1.03e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NCOA1—breast cancer	1.58e-06	1.02e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PTGS2—breast cancer	1.58e-06	1.02e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP19A1—breast cancer	1.56e-06	1.01e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—STK11—breast cancer	1.56e-06	1.01e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PIK3CA—breast cancer	1.55e-06	1e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—AKT1—breast cancer	1.53e-06	9.86e-06	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—AKT1—breast cancer	1.5e-06	9.67e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.46e-06	9.45e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—COMT—breast cancer	1.45e-06	9.36e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTP1—breast cancer	1.44e-06	9.32e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—HMOX1—breast cancer	1.42e-06	9.19e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ITPR1—breast cancer	1.42e-06	9.17e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—MED12—breast cancer	1.42e-06	9.14e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—DPYD—breast cancer	1.42e-06	9.14e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ALDOA—breast cancer	1.39e-06	9e-06	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PTEN—breast cancer	1.38e-06	8.89e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ABCB1—breast cancer	1.37e-06	8.82e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NCOA3—breast cancer	1.35e-06	8.73e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SLC2A2—breast cancer	1.34e-06	8.67e-06	CbGpPWpGaD
Zonisamide—CA9—Metabolism—AKT1—breast cancer	1.34e-06	8.66e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—TYMS—breast cancer	1.34e-06	8.66e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTM1—breast cancer	1.33e-06	8.56e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PLA2G4A—breast cancer	1.33e-06	8.56e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NCOR1—breast cancer	1.33e-06	8.56e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—MTR—breast cancer	1.32e-06	8.5e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CPT1A—breast cancer	1.32e-06	8.5e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ABCG2—breast cancer	1.32e-06	8.5e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—HPGDS—breast cancer	1.29e-06	8.33e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—HBA1—breast cancer	1.28e-06	8.28e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GPX1—breast cancer	1.27e-06	8.2e-06	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—AKT1—breast cancer	1.26e-06	8.17e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP1A1—breast cancer	1.26e-06	8.12e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ACHE—breast cancer	1.25e-06	8.08e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTT1—breast cancer	1.25e-06	8.08e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ERCC2—breast cancer	1.25e-06	8.05e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP17A1—breast cancer	1.19e-06	7.65e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ENO1—breast cancer	1.17e-06	7.57e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PTGS1—breast cancer	1.17e-06	7.57e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—MTHFR—breast cancer	1.17e-06	7.57e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP2D6—breast cancer	1.15e-06	7.43e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NCOA2—breast cancer	1.13e-06	7.29e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—FASN—breast cancer	1.1e-06	7.07e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—BCHE—breast cancer	1.09e-06	7.04e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CAV1—breast cancer	1.08e-06	6.98e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SLC5A5—breast cancer	1.08e-06	6.95e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NQO1—breast cancer	1.04e-06	6.72e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SLC2A1—breast cancer	1.04e-06	6.72e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.03e-06	6.67e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP1B1—breast cancer	9.97e-07	6.44e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PIK3CG—breast cancer	9.85e-07	6.36e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—HSP90AA1—breast cancer	9.78e-07	6.31e-06	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PIK3CA—breast cancer	9.72e-07	6.27e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NCOA1—breast cancer	9.52e-07	6.14e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP19A1—breast cancer	9.38e-07	6.05e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—STK11—breast cancer	9.38e-07	6.05e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—COMT—breast cancer	8.72e-07	5.63e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTP1—breast cancer	8.68e-07	5.6e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PIK3CD—breast cancer	8.66e-07	5.59e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—HMOX1—breast cancer	8.56e-07	5.52e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ALB—breast cancer	8.54e-07	5.52e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ITPR1—breast cancer	8.54e-07	5.51e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ABCB1—breast cancer	8.21e-07	5.3e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NOS3—breast cancer	8.17e-07	5.28e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—TYMS—breast cancer	8.07e-07	5.21e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PLA2G4A—breast cancer	7.97e-07	5.15e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTM1—breast cancer	7.97e-07	5.15e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NCOR1—breast cancer	7.97e-07	5.15e-06	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—AKT1—breast cancer	7.94e-07	5.12e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GPX1—breast cancer	7.64e-07	4.93e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP1A1—breast cancer	7.56e-07	4.88e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PIK3CB—breast cancer	7.54e-07	4.87e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ERCC2—breast cancer	7.5e-07	4.84e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PTGS2—breast cancer	7.48e-07	4.83e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—MTHFR—breast cancer	7.05e-07	4.55e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PTEN—breast cancer	6.52e-07	4.21e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CAV1—breast cancer	6.5e-07	4.2e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PIK3CG—breast cancer	5.92e-07	3.82e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PIK3CD—breast cancer	5.21e-07	3.36e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ALB—breast cancer	5.14e-07	3.32e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NOS3—breast cancer	4.92e-07	3.17e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PIK3CA—breast cancer	4.6e-07	2.97e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PIK3CB—breast cancer	4.54e-07	2.93e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PTGS2—breast cancer	4.5e-07	2.9e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PTEN—breast cancer	3.92e-07	2.53e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—AKT1—breast cancer	3.76e-07	2.43e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PIK3CA—breast cancer	2.77e-07	1.79e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—AKT1—breast cancer	2.26e-07	1.46e-06	CbGpPWpGaD
